SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 49 filers reported holding SYROS PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $465,000 | -60.3% | 483,711 | -50.9% | 0.00% | – |
| Q1 2022 | $1,172,000 | -62.3% | 985,231 | +3.4% | 0.00% | – |
| Q4 2021 | $3,107,000 | -18.9% | 953,200 | +11.1% | 0.00% | -100.0% |
| Q3 2021 | $3,833,000 | -27.2% | 857,646 | -11.3% | 0.00% | 0.0% |
| Q2 2021 | $5,267,000 | -15.5% | 966,448 | +16.0% | 0.00% | 0.0% |
| Q1 2021 | $6,230,000 | -2.7% | 833,008 | +41.2% | 0.00% | 0.0% |
| Q4 2020 | $6,402,000 | +24.7% | 590,102 | +1.6% | 0.00% | 0.0% |
| Q3 2020 | $5,133,000 | -14.6% | 580,709 | +3.0% | 0.00% | 0.0% |
| Q2 2020 | $6,010,000 | +103.5% | 563,801 | +13.2% | 0.00% | 0.0% |
| Q1 2020 | $2,954,000 | -55.1% | 498,187 | -47.6% | 0.00% | 0.0% |
| Q4 2019 | $6,572,000 | +40.3% | 951,092 | +110.7% | 0.00% | 0.0% |
| Q3 2019 | $4,685,000 | +13.5% | 451,425 | +1.2% | 0.00% | 0.0% |
| Q2 2019 | $4,129,000 | +55.5% | 445,922 | +53.5% | 0.00% | 0.0% |
| Q1 2019 | $2,655,000 | -4.5% | 290,531 | -41.8% | 0.00% | – |
| Q4 2018 | $2,780,000 | +3.1% | 499,336 | +120.5% | 0.00% | -100.0% |
| Q3 2018 | $2,696,000 | +22.9% | 226,434 | +5.3% | 0.00% | 0.0% |
| Q2 2018 | $2,194,000 | +3.3% | 214,944 | +31.4% | 0.00% | 0.0% |
| Q1 2018 | $2,123,000 | +128.0% | 163,567 | +70.8% | 0.00% | – |
| Q4 2017 | $931,000 | -33.3% | 95,755 | +0.9% | 0.00% | -100.0% |
| Q3 2017 | $1,396,000 | +3.6% | 94,891 | +13.2% | 0.00% | 0.0% |
| Q2 2017 | $1,348,000 | +111.3% | 83,821 | +109.2% | 0.00% | – |
| Q1 2017 | $638,000 | +46.7% | 40,058 | +11.8% | 0.00% | – |
| Q4 2016 | $435,000 | -9.6% | 35,836 | +3.1% | 0.00% | – |
| Q3 2016 | $481,000 | – | 34,750 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Ventures Fund IV General Partner LLC | 4,806,656 | $87,241,000 | 14.92% |
| Aisling Capital LLC | 908,565 | $16,490,000 | 3.89% |
| Foresite Capital Management III, LLC | 150,000 | $2,723,000 | 1.87% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,095,220 | $38,028,000 | 1.50% |
| Redmile Group, LLC | 946,182 | $15,058,000 | 1.44% |
| Casdin Capital, LLC | 50,000 | $908,000 | 0.90% |
| Eventide Asset Management | 150,000 | $2,723,000 | 0.17% |
| Weiss Multi-Strategy Advisers LLC | 45,857 | $832,000 | 0.06% |
| Baker Brothers Advisors | 204,465 | $3,711,000 | 0.04% |
| Alyeska Investment Group, L.P. | 70,000 | $1,271,000 | 0.01% |